Stock News That Gives You an Edge
Follow us on X for real-time stock news alerts
Stock News
S&P 500
Stock News
S&P 500
Main Pages
Stock News
Articles for $INKT
MiNK Therapeutics Reports Q4 and Full Year 2025 Results; Phase 2 Programs Advance with Impactful Non-Dilutive Momentum
MiNK Therapeutics Provides Update on Potential Combination Trials for agenT-797
MiNK Therapeutics Appoints New Principal Financial and Accounting Officers